272 related articles for article (PubMed ID: 32729415)
21. Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma.
Zhou D; Gao B; Yang Q; Kong Y; Wang W
Biomed Res Int; 2019; 2019():2601271. PubMed ID: 31886187
[TBL] [Abstract][Full Text] [Related]
22. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of ceRNA networks in HPV16- and HPV18-mediated cervical cancers reveals XIST as a pivotal competing endogenous RNA.
Berti FCB; Mathias C; Garcia LE; Gradia DF; de Araújo-Souza PS; Cipolla GA; de Oliveira JC; Malheiros D
Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166172. PubMed ID: 34048924
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
[TBL] [Abstract][Full Text] [Related]
25. Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network.
Hu D; Zhang B; Yu M; Shi W; Zhang L
Mol Med Rep; 2020 Aug; 22(2):620-632. PubMed ID: 32468035
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis of aberrantly expressed long non‑coding RNAs, microRNAs, and mRNAs associated with the competitive endogenous RNA network in cervical cancer.
Chen P; Zhang W; Chen Y; Zheng X; Yang D
Mol Med Rep; 2020 Jul; 22(1):405-415. PubMed ID: 32377727
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
[TBL] [Abstract][Full Text] [Related]
28. Integrated analysis of co-expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer.
Yao Y; Zhang T; Qi L; Zhou C; Wei J; Feng F; Liu R; Sun C
J Cell Mol Med; 2019 Dec; 23(12):8410-8419. PubMed ID: 31613058
[TBL] [Abstract][Full Text] [Related]
29. Integrated analysis of a competing endogenous RNA network reveals an 11-lncRNA prognostic signature in ovarian cancer.
Zhang Y; Zhou H; Zhang M; Xing L; Yang C; Xia B; Lou G
Aging (Albany NY); 2020 Nov; 12(24):25153-25171. PubMed ID: 33223503
[TBL] [Abstract][Full Text] [Related]
30. Functional Long Noncoding RNAs (lncRNAs) in Clear Cell Kidney Carcinoma Revealed by Reconstruction and Comprehensive Analysis of the lncRNA-miRNA-mRNA Regulatory Network.
Zhu H; Lu J; Zhao H; Chen Z; Cui Q; Lin Z; Wang X; Wang J; Dong H; Wang S; Tan J
Med Sci Monit; 2018 Nov; 24():8250-8263. PubMed ID: 30444862
[TBL] [Abstract][Full Text] [Related]
31. Analysis of competing endogenous RNA network identifies a poorly differentiated cancer-specific RNA signature for hepatocellular carcinoma.
Chen QF; Huang T; Si-Tu QJ; Wu P; Shen L; Li W; Huang Z
J Cell Biochem; 2020 Mar; 121(3):2303-2317. PubMed ID: 31642123
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of five long noncoding RNAs expression as competing endogenous RNAs in regulating hepatoma carcinoma.
Lou X; Li J; Yu D; Wei YQ; Feng S; Sun JJ
Cancer Med; 2019 Sep; 8(12):5735-5749. PubMed ID: 31392826
[TBL] [Abstract][Full Text] [Related]
33. Identification of biomarkers associated with the recurrence of osteosarcoma using ceRNA regulatory network analysis.
Zhang S; Ding L; Li X; Fan H
Int J Mol Med; 2019 Apr; 43(4):1723-1733. PubMed ID: 30816442
[TBL] [Abstract][Full Text] [Related]
34. Exploring prognostic potential of long noncoding RNAs in colorectal cancer based on a competing endogenous RNA network.
Yang ZD; Kang H
World J Gastroenterol; 2020 Mar; 26(12):1298-1316. PubMed ID: 32256018
[TBL] [Abstract][Full Text] [Related]
35. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
Tan J; Wang W; Song B; Song Y; Meng Z
Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
[TBL] [Abstract][Full Text] [Related]
36. A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
Yu H; Cheng Y; Li W; Li Z; Wu P; Qiu S; Zeng B; Huang B
Life Sci; 2020 Nov; 260():118409. PubMed ID: 32926921
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z
BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119
[TBL] [Abstract][Full Text] [Related]
38. A 6 lncRNA-Based Risk Score System for Predicting the Recurrence of Colon Adenocarcinoma Patients.
Yang H; Lin HC; Liu H; Gan D; Jin W; Cui C; Yan Y; Qian Y; Han C; Wang Z
Front Oncol; 2020; 10():81. PubMed ID: 32117736
[TBL] [Abstract][Full Text] [Related]
39. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Jin L; Li C; Liu T; Wang L
Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
[TBL] [Abstract][Full Text] [Related]
40. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]